GleanMark

BIOTRILLION Trademark

BIOTRILLION is a USPTO trademark filed by BioTrillion, Inc.. Status: Pending.

Trademark Facts

MarkBIOTRILLION
Serial Number97261958
StatusPending
Filing Date2022-02-10
Mark TypeWord
Nice Classes009 (Electronics & Software), 042 (Software & IT)
OwnerBioTrillion, Inc.
Attorney of RecordCaroline Chicoine
Prosecution Events33
Latest EventABN2 on 2025-05-27

Goods & Services

downloadable computer software platforms for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; Downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiological data; Downloadable computer software platforms for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; Downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, or drug effects or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; Downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; Software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; software as a service (SAAS) services featuring software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; software as a service (SAAS) services featuring downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, drug effects or drug use

Related